Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.

× No keyword cloud information.

48 in total

1. Quinolones and raised plasma concentrations of theophylline.

Authors: F P Maesen; J P Teengs; C Baur; B I Davies
Journal: Lancet Date: 1984-09-01 Impact factor: 79.321

2. Enoxacin raises plasma theophylline concentrations.

Authors: W J Wijnands; C L van Herwaarden; T B Vree
Journal: Lancet Date: 1984-07-14 Impact factor: 79.321

3. Pharmacokinetic studies of norfloxacin in laboratory animals.

Authors: E C Gilfillan; B A Pelak; J A Bland; P F Malatesta; H H Gadebusch
Journal: Chemotherapy Date: 1984 Impact factor: 2.544

4. Pharmacokinetics of intravenously administered ciprofloxacin.

Authors: R Wise; R M Lockley; M Webberly; J Dent
Journal: Antimicrob Agents Chemother Date: 1984-08 Impact factor: 5.191

5. Dose- and sex-independent disposition of ciprofloxacin.

Authors: D Höffler; A Dalhoff; W Gau; D Beermann; A Michl
Journal: Eur J Clin Microbiol Date: 1984-08 Impact factor: 3.267

6. The treatment of Pseudomonas aeruginosa urinary tract infections with norfloxacin.

Authors: D A Leigh; F X Emmanuel
Journal: J Antimicrob Chemother Date: 1984-05 Impact factor: 5.790

7. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.

Authors: S R Crider; S D Colby; L K Miller; W O Harrison; S B Kerbs; S W Berg
Journal: N Engl J Med Date: 1984-07-19 Impact factor: 91.245

8. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.

Authors: D A Leigh; E C Smith; J Marriner
Journal: J Antimicrob Chemother Date: 1984-05 Impact factor: 5.790

9. Treatment of acute urinary infection by norfloxacin or nalidixic acid/citrate: a multi-centre comparative study.

Authors: D S Reeves; R W Lacey; R V Mummery; M Mahendra; A J Bint; S W Newsom
Journal: J Antimicrob Chemother Date: 1984-05 Impact factor: 5.790

10. Pharmacokinetics and tissue penetration of enoxacin.

Authors: R Wise; R Lockley; J Dent; M Webberly
Journal: Antimicrob Agents Chemother Date: 1984-07 Impact factor: 5.191

111 in total

Review 1. Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors: J S Wolfson
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-12 Impact factor: 3.267

Review 2. Clinical role of protein binding of quinolones.

Authors: Eugénie Bergogne-Bérézin
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

3. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever.

Authors: R Ruiz Beltrán; J I Herrero Herrero
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-05 Impact factor: 3.267

4. Use of fluoroquinolones is the single most important risk factor for the high bacterial load in patients with nasal and gastrointestinal colonization by multidrug-resistant Acinetobacter baumannii.

Authors: V C C Cheng; J H K Chen; S Y C So; S C Y Wong; M K Yan; P H Chau; W M Lee; K K W To; J F W Chan; I F N Hung; P L Ho; K Y Yuen
Journal: Eur J Clin Microbiol Infect Dis Date: 2015-09-15 Impact factor: 3.267

Review 5. Treatment of genitourinary tract infections with fluoroquinolones: clinical efficacy in genital infections and adverse effects.

Authors: D C Hooper; J S Wolfson
Journal: Antimicrob Agents Chemother Date: 1989-10 Impact factor: 5.191

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.